
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $6.1M | -- | $3.2M | |
Revenue Growth (YoY) | -- | -- | -- | -25.32% | -- | |
Cost of Revenues | -- | -- | $2.1M | -- | $1.3M | |
Gross Profit | -- | -- | $4M | -- | $1.9M | |
Gross Profit Margin | -- | -- | 65.28% | -- | 58.96% | |
R&D Expenses | -- | $2.7M | $4.5M | $1.4M | $4M | |
Selling, General & Admin | -- | $14.6M | $16.3M | $4.3M | $25.3M | |
Other Inc / (Exp) | -- | -$400.8K | -$1.6M | -$18.1M | -$6.8M | |
Operating Expenses | -- | $17.3M | $21.6M | $5.7M | $29.9M | |
Operating Income | -- | -$17.3M | -$17.7M | -$5.7M | -$28M | |
Net Interest Expenses | -- | -- | $600K | $1.2M | $799K | |
EBT. Incl. Unusual Items | -- | -$18.4M | -$19.9M | -$25.1M | -$35.6M | |
Earnings of Discontinued Ops. | -- | -- | -$46.6M | -$12.8M | -- | |
Income Tax Expense | -- | -- | -$181K | -- | $16K | |
Net Income to Company | -- | -$18.4M | -$66.3M | -$25.1M | -$35.6M | |
Minority Interest in Earnings | -- | -- | $2.9M | $1.2M | -- | |
Net Income to Common Excl Extra Items | -- | -$18.4M | -$63.4M | -$25.1M | -$35.6M | |
Basic EPS (Cont. Ops) | -- | -$7,674.38 | -$26,370.22 | -$640.34 | -$21.95 | |
Diluted EPS (Cont. Ops) | -- | -$7,674.38 | -$26,370.22 | -$640.34 | -$21.95 | |
Weighted Average Basic Share | -- | $2.4K | $2.4K | $39.2K | $1.7M | |
Weighted Average Diluted Share | -- | $2.4K | $2.4K | $39.2K | $1.7M | |
EBITDA | -- | -$17.7M | -$11.1M | -$23.9M | -$33.5M | |
EBIT | -- | -$17.8M | -$19.3M | -$23.9M | -$34.4M | |
Revenue (Reported) | -- | -- | $6.1M | -- | $3.2M | |
Operating Income (Reported) | -- | -$17.3M | -$17.7M | -$5.7M | -$28M | |
Operating Income (Adjusted) | -- | -$17.8M | -$19.3M | -$23.9M | -$34.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $220K | $484K | |
Revenue Growth (YoY) | -- | -- | -- | -- | 120% | |
Cost of Revenues | -- | -- | -- | $79K | $149K | |
Gross Profit | -- | -- | -- | $141K | $335K | |
Gross Profit Margin | -- | -- | -- | 64.09% | 69.22% | |
R&D Expenses | -- | $1M | $435K | $464K | $1.7M | |
Selling, General & Admin | -- | $6.1M | $705K | $2M | $8.4M | |
Other Inc / (Exp) | -- | -$1.1M | -$163K | $67K | -$2.8M | |
Operating Expenses | -- | $7.1M | $1.1M | $2.5M | $10.2M | |
Operating Income | -- | -$7.1M | -$1.1M | -$2.4M | -$9.9M | |
Net Interest Expenses | -- | -- | -- | $278K | $217K | |
EBT. Incl. Unusual Items | -- | -$8.4M | -$1.6M | -$2.6M | -$12.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $4K | -$15K | |
Net Income to Company | -- | -$8.4M | -$1.6M | -$2.6M | -$12.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$8.4M | -$1.6M | -$2.6M | -$12.9M | |
Basic EPS (Cont. Ops) | -- | -$3,477.89 | -$651.00 | -$124.05 | -$3.80 | |
Diluted EPS (Cont. Ops) | -- | -$3,477.89 | -$651.00 | -$124.05 | -$3.80 | |
Weighted Average Basic Share | -- | $2.4K | $2.4K | $21.5K | $3.4M | |
Weighted Average Diluted Share | -- | $2.4K | $2.4K | $21.5K | $3.4M | |
EBITDA | -- | -$8.2M | -$1.3M | -$2.3M | -$12.5M | |
EBIT | -- | -$8.2M | -$1.3M | -$2.3M | -$12.7M | |
Revenue (Reported) | -- | -- | -- | $220K | $484K | |
Operating Income (Reported) | -- | -$7.1M | -$1.1M | -$2.4M | -$9.9M | |
Operating Income (Adjusted) | -- | -$8.2M | -$1.3M | -$2.3M | -$12.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | $3.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | $1.4M | |
Gross Profit | -- | -- | -- | $141K | $2.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | $1.4M | $5.2M | |
Selling, General & Admin | -- | -- | -- | $5.7M | $31.6M | |
Other Inc / (Exp) | -- | -$1.1M | -$1.2M | -$17.9M | -$9.7M | |
Operating Expenses | -- | -- | -- | $7.1M | $37.5M | |
Operating Income | -- | -- | -- | -$7M | -$35.5M | |
Net Interest Expenses | -- | -- | -- | $278K | $738K | |
EBT. Incl. Unusual Items | -- | -- | -- | -$26.1M | -$45.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $4K | -$3K | |
Net Income to Company | -- | -- | -- | -$26.1M | -$45.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -$26.1M | -$45.9M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -$3,587.02 | -$307.24 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -$3,587.02 | -$307.24 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -$24.8M | -$43.7M | |
EBIT | -- | -- | -- | -$24.9M | -$44.8M | |
Revenue (Reported) | -- | -- | -- | -- | $3.5M | |
Operating Income (Reported) | -- | -- | -- | -$7M | -$35.5M | |
Operating Income (Adjusted) | -- | -- | -- | -$24.9M | -$44.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $220K | $484K | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | $79K | $149K | |
Gross Profit | -- | -- | -- | $141K | $335K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $1M | $435K | $464K | $1.7M | |
Selling, General & Admin | -- | $6.1M | $705K | $2M | $8.4M | |
Other Inc / (Exp) | -- | -$1.1M | -$163K | $67K | -$2.8M | |
Operating Expenses | -- | $7.1M | $1.1M | $2.5M | $10.2M | |
Operating Income | -- | -$7.1M | -$1.1M | -$2.4M | -$9.9M | |
Net Interest Expenses | -- | -- | -- | $278K | $217K | |
EBT. Incl. Unusual Items | -- | -$8.4M | -$1.6M | -$2.6M | -$12.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $4K | -$15K | |
Net Income to Company | -- | -$8.4M | -$1.6M | -$2.6M | -$12.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$8.4M | -$1.6M | -$2.6M | -$12.9M | |
Basic EPS (Cont. Ops) | -- | -$3,477.89 | -$651.00 | -$124.05 | -$3.80 | |
Diluted EPS (Cont. Ops) | -- | -$3,477.89 | -$651.00 | -$124.05 | -$3.80 | |
Weighted Average Basic Share | -- | $2.4K | $2.4K | $21.5K | $3.4M | |
Weighted Average Diluted Share | -- | $2.4K | $2.4K | $21.5K | $3.4M | |
EBITDA | -- | -$8.2M | -$1.3M | -$2.3M | -$12.5M | |
EBIT | -- | -$8.2M | -$1.3M | -$2.3M | -$12.7M | |
Revenue (Reported) | -- | -- | -- | $220K | $484K | |
Operating Income (Reported) | -- | -$7.1M | -$1.1M | -$2.4M | -$9.9M | |
Operating Income (Adjusted) | -- | -$8.2M | -$1.3M | -$2.3M | -$12.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $4.3M | $9.3M | $6.3M | $4.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | $1.2M | $568K | $706K | |
Inventory | -- | -- | $2M | $2.4M | $2.2M | |
Prepaid Expenses | -- | $79.4K | -- | -- | $934K | |
Other Current Assets | -- | -- | $2.7M | $430K | $84K | |
Total Current Assets | -- | $4.6M | $29.9M | $20.5M | $8.6M | |
Property Plant And Equipment | -- | $31.6K | $869K | $612K | $546K | |
Long-Term Investments | -- | -- | $666K | -- | -- | |
Goodwill | -- | -- | -- | -- | $12.1M | |
Other Intangibles | -- | $302K | $3.5M | $2.5M | $1.9M | |
Other Long-Term Assets | -- | -- | $22.7M | $145K | $1.2M | |
Total Assets | -- | $4.9M | $57.6M | $23.8M | $24.3M | |
Accounts Payable | -- | $454.2K | $720K | $2.4M | $5.5M | |
Accrued Expenses | -- | $410K | $1.8M | $1.2M | $950K | |
Current Portion Of Long-Term Debt | -- | $1.1M | -- | -- | -$211K | |
Current Portion Of Capital Lease Obligations | -- | -- | $207K | $201K | $119K | |
Other Current Liabilities | -- | $6.1M | $8.8M | $2.9M | -- | |
Total Current Liabilities | -- | $10M | $24.7M | $16.9M | $17.4M | |
Long-Term Debt | -- | $3.4M | -- | -- | $65K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $13.4M | $25.5M | $17M | $17.7M | |
Common Stock | -- | $35.6K | -- | $3K | $1.3M | |
Other Common Equity Adj | -- | -- | $1.1M | $630K | -$622K | |
Common Equity | -- | -$8.5M | $33.3M | $6.3M | $5.2M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -$1.2M | $390K | -- | |
Total Equity | -- | -$8.5M | $32.1M | $6.7M | $6.6M | |
Total Liabilities and Equity | -- | $4.9M | $57.6M | $23.8M | $24.3M | |
Cash and Short Terms | -- | $4.3M | $9.3M | $6.3M | $4.1M | |
Total Debt | -- | -- | $12.6M | $8.7M | $2.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | $372.9K | $1.8M | $8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | $797K | $573K | |
Inventory | -- | -- | -- | $2.9M | $2.3M | |
Prepaid Expenses | -- | -- | $23.1K | -- | $1.5M | |
Other Current Assets | -- | -- | -- | $1.7M | $91K | |
Total Current Assets | -- | -- | $523.5K | $11.5M | $12.5M | |
Property Plant And Equipment | -- | -- | $17K | $903K | $512K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | $12.4M | $12.4M | |
Other Intangibles | -- | -- | $272.8K | $5M | $1.3M | |
Other Long-Term Assets | -- | -- | -- | $914K | $362K | |
Total Assets | -- | -- | $813.2K | $30.8M | $27.1M | |
Accounts Payable | -- | -- | $1.7M | $6.9M | $3.9M | |
Accrued Expenses | -- | -- | $908.4K | $1.3M | $801K | |
Current Portion Of Long-Term Debt | -- | -- | $1.6M | $222K | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | $259K | $91K | |
Other Current Liabilities | -- | -- | $5.7M | $1.8M | $4.4M | |
Total Current Liabilities | -- | -- | $13.1M | $16.6M | $12.5M | |
Long-Term Debt | -- | -- | $4.1M | $65K | $65K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | $17.2M | $17.1M | $12.8M | |
Common Stock | -- | -- | $34.6K | $11.3M | $5K | |
Other Common Equity Adj | -- | -- | -- | -$166K | -$155K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -$1.4M | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -$16.4M | $13.7M | $14.3M | |
Total Liabilities and Equity | -- | -- | $813.2K | $30.8M | $27.1M | |
Cash and Short Terms | -- | -- | $372.9K | $1.8M | $8M | |
Total Debt | -- | -- | -- | $903K | $65K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$18.4M | -$66.3M | -$25.1M | -$35.6M | |
Depreciation & Amoritzation | -- | $30K | $8.2M | $38K | $972K | |
Stock-Based Compensation | -- | $12.5M | $3.7M | $1.6M | $4.1M | |
Change in Accounts Receivable | -- | -$249.6K | -$115K | $26K | -$18K | |
Change in Inventories | -- | -- | -$565K | -- | $611K | |
Cash From Operations | -- | -$4.4M | -$34M | -$4.2M | -$22.3M | |
Capital Expenditures | -- | -- | $1.2M | $17K | $115K | |
Cash Acquisitions | -- | -- | -- | -- | $3M | |
Cash From Investing | -- | -$47.2K | $36.4M | -$17K | $2.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$10M | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $2.6M | $12.3M | $3.9M | $3M | |
Long-Term Debt Repaid | -- | -$139.1K | -- | -$14K | -$868K | |
Repurchase of Common Stock | -- | -- | -$102.4M | -- | -$795K | |
Other Financing Activities | -- | $5.5M | -$5.5M | -$566K | -- | |
Cash From Financing | -- | $8.7M | -$34.6M | $4.1M | $23.6M | |
Beginning Cash (CF) | -- | $122.9K | $52.5M | $115K | $5K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $4.2M | -$32.2M | -$110K | $4.1M | |
Ending Cash (CF) | -- | $4.3M | $20.2M | $5K | $4.1M | |
Levered Free Cash Flow | -- | -$4.5M | -$35.2M | -$4.2M | -$22.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$8.4M | -$1.6M | -$2.6M | -$12.9M | |
Depreciation & Amoritzation | -- | $9.2K | $10K | $66K | $176K | |
Stock-Based Compensation | -- | $1.7M | $141K | $5.8M | $455K | |
Change in Accounts Receivable | -- | $25K | -$1K | -$143K | $157K | |
Change in Inventories | -- | -- | -- | $373K | -$19K | |
Cash From Operations | -- | -$1.8M | -$457K | -$2.6M | -$15.2M | |
Capital Expenditures | -- | -- | -- | $10K | $45K | |
Cash Acquisitions | -- | -- | -- | $3M | -- | |
Cash From Investing | -- | -$970 | -- | $3M | -$45K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $715K | $1.4M | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$2.7M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$1.4M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | $50.2K | $715K | $1.4M | $19.2M | |
Beginning Cash (CF) | -- | $4.3M | $115K | $5K | $4.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -$1K | $17K | |
Additions / Reductions | -- | -$1.8M | $258K | $1.8M | $3.9M | |
Ending Cash (CF) | -- | $2.5M | $373K | $1.8M | $8M | |
Levered Free Cash Flow | -- | -$1.8M | -$457K | -$2.6M | -$15.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$26.1M | -$45.9M | |
Depreciation & Amoritzation | -- | -- | -- | $94K | $1.1M | |
Stock-Based Compensation | -- | $1.7M | $2M | $7.3M | -$1.2M | |
Change in Accounts Receivable | -- | -- | -- | -$116K | $282K | |
Change in Inventories | -- | -- | -- | $373K | $219K | |
Cash From Operations | -- | -- | -- | -$6.3M | -$35M | |
Capital Expenditures | -- | -- | -- | $10K | $150K | |
Cash Acquisitions | -- | -- | -- | $3M | -- | |
Cash From Investing | -- | -- | -- | $2.9M | -$150K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $4.6M | $1.6M | |
Long-Term Debt Repaid | -- | -- | -- | -$14K | -$3.6M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | $4.8M | $41.3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | $1.4M | $6.2M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -$6.3M | -$35.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$8.4M | -$1.6M | -$2.6M | -$12.9M | |
Depreciation & Amoritzation | -- | $9.2K | $10K | $66K | $176K | |
Stock-Based Compensation | -- | $1.7M | $141K | $5.8M | $455K | |
Change in Accounts Receivable | -- | $25K | -$1K | -$143K | $157K | |
Change in Inventories | -- | -- | -- | $373K | -$19K | |
Cash From Operations | -- | -$1.8M | -$457K | -$2.6M | -$15.2M | |
Capital Expenditures | -- | -- | -- | $10K | $45K | |
Cash Acquisitions | -- | -- | -- | $3M | -- | |
Cash From Investing | -- | -$970 | -- | $3M | -$45K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $715K | $1.4M | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$2.7M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$1.4M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | $50.2K | $715K | $1.4M | $19.2M | |
Beginning Cash (CF) | -- | $4.3M | $115K | $5K | $4.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -$1K | $17K | |
Additions / Reductions | -- | -$1.8M | $258K | $1.8M | $3.9M | |
Ending Cash (CF) | -- | $2.5M | $373K | $1.8M | $8M | |
Levered Free Cash Flow | -- | -$1.8M | -$457K | -$2.6M | -$15.3M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.